Lorena Petrella

Dr. Lorena Petrella


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2018 in Human Molecular Genetics
Verified
Journal Article
Closed access
PDF file
LPLorena Petrella
Lorena Petrella
Joao CastelhanoJoao Castelhano
Joao Castelhano
MRMario Ribeiro
Mario Ribeiro
JSJosé Sereno
José Sereno
SGSónia I Gonçalves
Sónia I Gonçalves
Miguel Castelo-BrancoMiguel Castelo-Branco
Miguel Castelo-Branco
Huntington’s disease (HD) is a neurodegenerative disorder causing cognitive and motor impairments, evolving to death within 15-20 years after symptom onset. We previously established a mouse model with the entire human HD gene containing 128 CAG repeats (YAC128) which accurately recapitulates the natural history of the human disease. Defined time points in this natural history enable the understanding of longitudinal trajectories from the neurochemical and structural points of view using non-invasive high-resolution multimodal imaging. Accordingly, we designed a longitudinal structural imaging (MRI and DTI) and spectroscopy (1H MRS) study in YAC128, at three, six, nine and twelve months of age, at 9.4 T. Structural analysis (MRI/DTI), confirmed that the striatum is the earliest affected brain region, but other regions were also identified through connectivity analysis (pre-frontal cortex, hippocampus, globus pallidus and thalamus), suggesting a striking homology with the human disease. Importantly, we found for the first time, a negative correlation between striatal and hippocampal changes only in YAC128. In fact, the striatum showed accelerated volumetric decay in HD, as opposed to the hippocampus. Neurochemical analysis of the HD striatum suggested early neurometabolic alterations in neurotransmission and metabolism, with a significant increase in striatal GABA levels, and specifically anticorrelated levels of N-acetyl aspartate and taurine, suggesting that the later is homeostatically adjusted for neuroprotection, as neural loss, indicated by the former, is progressing. These results provide novel insights into the natural history of HD and prove a valuable role for longitudinal multimodal panels of structural and metabolite/neurotransmission in the YAC128 model.

1 September 2018 in Molecular Therapy
Verified
Journal Article
Open access
CMCatarina Miranda
Catarina Miranda
AMAdriana Marcelo
Adriana Marcelo
TSTeresa Pereira Silva
Teresa Pereira Silva
JBJoão Barata
João Barata
AVAna Vasconcelos-Ferreira
Ana Vasconcelos-Ferreira
LALuis Pereira De Almeida
Luis Pereira De Almeida
Machado-Joseph disease (MJD) or spinocerebellar ataxia type 3, the most common dominant spinocerebellar ataxia (SCA) worldwide, is caused by over-repetition of a CAG repeat in the ATXN3/MJD1 gene, which translates into a polyglutamine tract within the ataxin-3 protein. There is no treatment for this fatal disorder. Despite evidence of the safety and efficacy of mesenchymal stromal cells (MSCs) in delaying SCA disease progression in exploratory clinical trials, unanticipated regression of patients to the status prior to treatment makes the investigation of causes and solutions urgent and imperative. In the present study, we compared the efficacy of a single intracranial injection with repeated systemic MSC administration in alleviating the MJD phenotype of two strongly severe genetic rodent models. We found that a single MSC transplantation only produces transient effects, whereas periodic administration promotes sustained motor behavior and neuropathology alleviation, suggesting that MSC therapies should be re-designed to get sustained beneficial results in clinical practice. Furthermore, MSC promoted neuroprotection, increased the levels of GABA and glutamate, and decreased the levels of Myo-inositol, which correlated with motor improvements, indicating that these metabolites may serve as valid neurospectroscopic biomarkers of disease and treatment. This study makes important contributions to the design of new clinical approaches for MJD and other SCAs/polyglutamine disorders.

10 June 2016 in Genes, Brain and Behavior
Verified
Journal Article
Open access
PDF file
LPLorena Petrella
Lorena Petrella
YCY. Cai
Y. Cai
JSJosé Sereno
José Sereno
SGS. I. Gonçalves
S. I. Gonçalves
ASA. J. Silva
A. J. Silva
Miguel Castelo-BrancoMiguel Castelo-Branco
Miguel Castelo-Branco
Neurofibromatosis type‐1 (NF1) is a common neurogenetic disorder and an important cause of intellectual disability. Brain‐behaviour associations can be examined in vivo using morphometric magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) to study brain structure. Here, we studied structural and behavioural phenotypes in heterozygous Nf1 mice (Nf1+/−) using T2‐weighted imaging MRI and DTI, with a focus on social recognition deficits. We found that Nf1+/− mice have larger volumes than wild‐type (WT) mice in regions of interest involved in social cognition, the prefrontal cortex (PFC) and the caudate‐putamen (CPu). Higher diffusivity was found across a distributed network of cortical and subcortical brain regions, within and beyond these regions. Significant differences were observed for the social recognition test. Most importantly, significant structure–function correlations were identified concerning social recognition performance and PFC volumes in Nf1+/− mice. Analyses of spatial learning corroborated the previously known deficits in the mutant mice, as corroborated by platform crossings, training quadrant time and average proximity measures. Moreover, linear discriminant analysis of spatial performance identified 2 separate sub‐groups in Nf1+/− mice. A significant correlation between quadrant time and CPu volumes was found specifically for the sub‐group of Nf1+/− mice with lower spatial learning performance, suggesting additional evidence for reorganization of this region. We found strong evidence that social and spatial cognition deficits can be associated with PFC/CPu structural changes and reorganization in NF1.


1 August 2014 in Ultrasonics
Verified
Journal Article
Closed access
LPLorena Petrella
Lorena Petrella
LMLuis E. Maggi
Luis E. Maggi
RSRaquel M. Souza
Raquel M. Souza
AAAndré V. Alvarenga
André V. Alvarenga
RCRodrigo P.B. Costa-Félix
Rodrigo P.B. Costa-Félix

1 July 2022 in The Journal of the Acoustical Society of America
Verified
Journal Article
Open access
Diogo PessoaDiogo Pessoa
Diogo Pessoa
LPLorena Petrella
Lorena Petrella
PMPedro Martins
Pedro Martins
Miguel Castelo-BrancoMiguel Castelo-Branco
Miguel Castelo-Branco
CTCesar Teixeira
Cesar Teixeira
This paper addresses the development of a system for classifying mouse ultrasonic vocalizations (USVs) present in audio recordings. The automatic labeling process for USVs is usually divided into two main steps: USV segmentation followed by the matching classification. Three main contributions can be highlighted: (i) a new segmentation algorithm, (ii) a new set of features, and (iii) the discrimination of a higher number of classes when compared to similar studies. The developed segmentation algorithm is based on spectral entropy analysis. This novel segmentation approach can detect USVs with 94% and 74% recall and precision, respectively. When compared to other methods/software, our segmentation algorithm achieves a higher recall. Regarding the classification phase, besides the traditional features from time, frequency, and time-frequency domains, a new set of contour-based features were extracted and used as inputs of shallow machine learning classification models. The contour-based features were obtained from the time-frequency ridge representation of USVs. The classification methods can differentiate among ten different syllable types with 81.1% accuracy and 80.5% weighted F1-score. The algorithms were developed and evaluated based on a large dataset, acquired on diverse social interaction conditions between the animals, to stimulate a varied vocal repertoire.